Webcast: Outlook for COVID-19 Vaccines and their 2021 Economic Impact< 1 min read
In the latest episode of Fortunato & Friends, Exelon Chief Economist Ed Fortunato interviews Dr. Wilbur H. Chen, a professor of medicine at the University of Maryland School of Medicine, director of the University of the Maryland, Baltimore, Travel Medicine Practice, and chief of the Adult Clinical Studies section at the Center for Vaccine Development and Global Health.
They discuss Dr. Chen’s expectations for COVID-19 vaccines and how their approval and distribution will impact the economy in 2021. Keith Poli, a member of Constellation’s Commodities Management Group, moderated the conversation and shared insights.
The three speakers deliberated on the following questions (and more):
- What have we learned since March about the impact of COVID-19 on both people and the economy?
- What is mRNA technology that is being used in potential vaccines? Has it been used before? How will the various vaccines in development work compared with traditional forms?
- Are there any future medical silver linings that we have uncovered, such as faster vaccine development without sacrificing safety or efficacy? Will COVID-19 research provide unintended benefits to future prevention of heart attacks, diabetes, cancer, etc.?
- Are there specific benchmarks that reveal a vaccine’s effectiveness? What will give the public confidence in these vaccines?
- Was the current increase in cases expected, and are there additional shutdowns or other milestones that people and businesses should anticipate this winter?
- How will economic recovery look following scaled vaccine distribution?
Listen to the full webcast below to hear expert insights.
Every month, Fortunato & Friends, a live webcast interview, will feature a special guest to discuss topics driving the economy and energy markets. Register for the next Fortunato & Friends webcast todaay.